123 related articles for article (PubMed ID: 38148630)
21. Non-POU Domain-Containing Octomer-Binding (NONO) protein expression and stability promotes the tumorigenicity and activation of Akt/MAPK/β-catenin pathways in human breast cancer cells.
Lone BA; Siraj F; Sharma I; Verma S; Karna SKL; Ahmad F; Nagar P; Sachidanandan C; Pokharel YR
Cell Commun Signal; 2023 Jun; 21(1):157. PubMed ID: 37370134
[TBL] [Abstract][Full Text] [Related]
22. NonO Is a Novel Co-factor of PRDM1 and Regulates Inflammatory Response in Monocyte Derived-Dendritic Cells.
Lee K; Jang SH; Tian H; Kim SJ
Front Immunol; 2020; 11():1436. PubMed ID: 32765503
[TBL] [Abstract][Full Text] [Related]
23. Synergistic upregulation of NONO and PSPC1 regulates Sertoli cell response to MEHP via modulation of ALDH1A1 signaling.
Dong BW; Jin XH; Yan CY; Yang T; Cai GQ; Lu J
FEBS Lett; 2017 Mar; 591(6):914-923. PubMed ID: 28117896
[TBL] [Abstract][Full Text] [Related]
24. Structure, Dynamics, and Interaction of p54(nrb)/NonO RRM1 with 5' Splice Site RNA Sequence.
Duvignaud JB; Bédard M; Nagata T; Muto Y; Yokoyama S; Gagné SM; Vincent M
Biochemistry; 2016 May; 55(18):2553-66. PubMed ID: 27064654
[TBL] [Abstract][Full Text] [Related]
25. NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
Xie R; Chen X; Cheng L; Huang M; Zhou Q; Zhang J; Chen Y; Peng S; Chen Z; Dong W; Huang J; Lin T
Mol Ther; 2021 Jan; 29(1):291-307. PubMed ID: 32950106
[TBL] [Abstract][Full Text] [Related]
26. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14.
Yang ZY; Zhao C; Liu SL; Pan LJ; Zhu YD; Zhao JW; Wang HK; Ye YY; Qiang J; Shi LQ; Mei JW; Xie Y; Gong W; Shu YJ; Dong P; Xiang SS
Cancer Lett; 2024 Apr; 587():216703. PubMed ID: 38341127
[TBL] [Abstract][Full Text] [Related]
27. NONO enhances mRNA processing of super-enhancer-associated GATA2 and HAND2 genes in neuroblastoma.
Zhang S; Cooper JA; Chong YS; Naveed A; Mayoh C; Jayatilleke N; Liu T; Amos S; Kobelke S; Marshall AC; Meers O; Choi YS; Bond CS; Fox AH
EMBO Rep; 2023 Feb; 24(2):e54977. PubMed ID: 36416237
[TBL] [Abstract][Full Text] [Related]
28. Nucleolar detention of NONO shields DNA double-strand breaks from aberrant transcripts.
Trifault B; Mamontova V; Cossa G; Ganskih S; Wei Y; Hofstetter J; Bhandare P; Baluapuri A; Nieto B; Solvie D; Ade CP; Gallant P; Wolf E; Larsen DH; Munschauer M; Burger K
Nucleic Acids Res; 2024 Apr; 52(6):3050-3068. PubMed ID: 38224452
[TBL] [Abstract][Full Text] [Related]
29. NonO enhances the association of many DNA-binding proteins to their targets.
Yang YS; Yang MC; Tucker PW; Capra JD
Nucleic Acids Res; 1997 Jun; 25(12):2284-92. PubMed ID: 9171077
[TBL] [Abstract][Full Text] [Related]
30. Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism.
Laurenzi T; Palazzolo L; Taiana E; Saporiti S; Ben Mariem O; Guerrini U; Neri A; Eberini I
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886974
[TBL] [Abstract][Full Text] [Related]
31. Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b).
Desai SS; Kharade SS; Parekh VI; Iyer S; Agarwal SK
J Biol Chem; 2015 Oct; 290(42):25595-608. PubMed ID: 26342078
[TBL] [Abstract][Full Text] [Related]
32. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA.
Ding H; Liu J; Wang C; Su Y
Cancer Cell Int; 2020; 20():425. PubMed ID: 32884448
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response.
Salton M; Lerenthal Y; Wang SY; Chen DJ; Shiloh Y
Cell Cycle; 2010 Apr; 9(8):1568-76. PubMed ID: 20421735
[TBL] [Abstract][Full Text] [Related]
34. RNA-binding protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
[TBL] [Abstract][Full Text] [Related]
35. RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8.
Iino K; Mitobe Y; Ikeda K; Takayama KI; Suzuki T; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jan; 111(1):148-159. PubMed ID: 31733123
[TBL] [Abstract][Full Text] [Related]
36. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
Lu JY; Sewer MB
Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
[TBL] [Abstract][Full Text] [Related]
37. NONO regulates multiple cytokine production in sepsis via the ERK1/2 signaling pathway.
Niu Y; Xu G; Zhu S; Wei X; Wu C; Zhang R; Chen C; Yan L; Luo H; Deng S; Wu W; Li Y; Liu M; Jiang Y; Zhang X
Mol Immunol; 2023 Jan; 153():94-105. PubMed ID: 36459792
[TBL] [Abstract][Full Text] [Related]
38.
Trifault B; Mamontova V; Burger K
Front Mol Biosci; 2022; 9():914873. PubMed ID: 35733943
[TBL] [Abstract][Full Text] [Related]
39. Silencing of NONO inhibits abdominal aortic aneurysm in apolipoprotein E-knockout mice via collagen deposition and inflammatory inhibition.
Xu X; Zhang F; Lu Y; Yu S; Sun W; Sun S; Cheng J; Ma J; Zhang M; Zhang C; Zhang Y; Zhang K
J Cell Mol Med; 2019 Nov; 23(11):7449-7461. PubMed ID: 31512366
[TBL] [Abstract][Full Text] [Related]
40. Quantitative proteomics reveals dynamic interaction of c-Jun N-terminal kinase (JNK) with RNA transport granule proteins splicing factor proline- and glutamine-rich (Sfpq) and non-POU domain-containing octamer-binding protein (Nono) during neuronal differentiation.
Sury MD; McShane E; Hernandez-Miranda LR; Birchmeier C; Selbach M
Mol Cell Proteomics; 2015 Jan; 14(1):50-65. PubMed ID: 25326457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
